Perceptive Advisors Llc's Net Worth
Perceptive Advisors Llc's net worth is estimated to be at least $494,119,330.90 as of 01/31/2023. CoreStreet's estimation of Perceptive Advisors Llc's net worth is based on their sale of stock and current holding of stock.
Perceptive Advisors Llc is Director at Astria Therapeutics Inc. They have executed at least 98 trades of stock as per SEC Form 4 filings. Their most recent trade was for 908,265 units of ATXS stock on 12/19/2022. Their biggest sale was on 12/01/2021 when they sold 2,707,463 units of VBI Vaccines Inc stock for $8,961,702.53. They typically trade 9 times per year.
Total value of insider buys:
- $440,866,831.27
Total value of insider sells:
- $53,252,499.63
Most recent insider trade:
- Dec. 19, 2022
Perceptive Advisors Llc's Insider Trading History
| Astria Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 19, 2022 | Director | 908,265 | $11.01 | Buy | $9,999,997.65 |
| Quotient Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 31, 2022 | Major Shareholder | 8,255,607 | $0.08 | Sell | $660,448.56 |
Sept. 15, 2020 | Major Shareholder | 2,911,764 | $4.25 | Buy | $12,374,997.00 |
Nov. 7, 2019 | Major Shareholder | 2,500,000 | $7.00 | Buy | $17,500,000.00 |
| Albireo Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 13, 2022 | Major Shareholder | 179,132 | $22.01 | Sell | $3,942,695.32 |
Oct. 11, 2022 | Major Shareholder | 144,065 | $23.54 | Sell | $3,391,290.10 |
Feb. 3, 2020 | Major Shareholder | 255,809 | $21.00 | Buy | $5,371,989.00 |
| LianBio ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 18, 2022 | Director | 998,240 | $2.40 | Buy | $2,395,776.00 |
| Cerevel Therapeutics Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2022 | Director | 1,425,000 | $35.00 | Buy | $49,875,000.00 |
Aug. 25, 2021 | Director | 61,387 | $28.57 | Buy | $1,753,826.59 |
Aug. 23, 2021 | Director | 44,437 | $25.78 | Buy | $1,145,585.86 |
July 7, 2021 | Director | 200,000 | $25.00 | Buy | $5,000,000.00 |
| Aldeyra The | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 10, 2022 | Major Shareholder | 15,000 | $7.85 | Buy | $117,750.00 |
Aug. 8, 2022 | Major Shareholder | 97,000 | $7.24 | Buy | $702,280.00 |
Aug. 3, 2022 | Major Shareholder | 100,000 | $5.84 | Buy | $584,000.00 |
Aug. 1, 2022 | Major Shareholder | 144,185 | $5.05 | Buy | $728,134.25 |
July 28, 2022 | Major Shareholder | 119,392 | $5.00 | Buy | $596,960.00 |
May 3, 2021 | Major Shareholder | 1,200,000 | $12.50 | Buy | $15,000,000.00 |
Jan. 19, 2021 | Major Shareholder | 1,368,421 | $9.50 | Buy | $12,999,999.50 |
Jan. 7, 2021 | Major Shareholder | 500,000 | $8.13 | Buy | $4,065,000.00 |
July 9, 2020 | Major Shareholder | 3,200,000 | $4.25 | Buy | $13,600,000.00 |
Feb. 14, 2017 | Major Shareholder | 893,025 | $4.50 | Buy | $4,018,612.50 |
May 26, 2016 | Major Shareholder | 700,000 | $5.00 | Buy | $3,500,000.00 |
Oct. 26, 2015 | Major Shareholder | 50,000 | $6.46 | Buy | $323,000.00 |
Oct. 22, 2015 | Major Shareholder | 18,020 | $6.47 | Buy | $116,589.40 |
Oct. 20, 2015 | Major Shareholder | 37,145 | $6.39 | Buy | $237,356.55 |
| Verrica Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 5, 2022 | Major Shareholder | 1,428,571 | $2.10 | Buy | $2,999,999.10 |
| Athira Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 29, 2022 | Director | 270,000 | $2.99 | Buy | $807,300.00 |
Jan. 25, 2021 | Director | 311,111 | $22.50 | Buy | $6,999,997.50 |
| Crinetics Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 18, 2022 | Major Shareholder | 157,515 | $22.22 | Buy | $3,499,983.30 |
Oct. 25, 2021 | Major Shareholder | 1,200,000 | $19.80 | Buy | $23,760,000.00 |
April 8, 2021 | Major Shareholder | 304,136 | $16.44 | Buy | $4,999,995.84 |
| Nautilus Biotechnology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 8, 2021 | Director | 200,000 | $5.36 | Buy | $1,072,000.00 |
| VBI Vaccines Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 1, 2021 | Major Shareholder | 2,707,463 | $3.31 | Sell | $8,961,702.53 |
June 29, 2021 | Major Shareholder | 646,257 | $3.80 | Sell | $2,455,776.60 |
June 9, 2021 | Major Shareholder | 1,422,567 | $4.00 | Sell | $5,690,268.00 |
Sept. 23, 2019 | Major Shareholder | 20,000,000 | $0.50 | Buy | $10,000,000.00 |
Dec. 13, 2018 | Major Shareholder | 14,285,714 | $1.40 | Buy | $19,999,999.60 |
Dec. 6, 2016 | Major Shareholder | 3,383,955 | $3.05 | Buy | $10,321,062.75 |
Aug. 14, 2015 | Major Shareholder | 650,000 | $2.08 | Buy | $1,352,000.00 |
| Agile Thrpe | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 13, 2021 | Major Shareholder | 5,734,560 | $0.85 | Buy | $4,874,376.00 |
March 13, 2020 | Major Shareholder | 1,000,000 | $1.75 | Buy | $1,750,000.00 |
Nov. 14, 2019 | Major Shareholder | 435,015 | $1.69 | Buy | $735,175.35 |
Oct. 28, 2019 | Major Shareholder | 3,815,349 | $0.51 | Sell | $1,945,827.99 |
Aug. 6, 2019 | Major Shareholder | 2,300,000 | $0.95 | Buy | $2,185,000.00 |
| Rain Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 11, 2021 | Major Shareholder | 21,826 | $12.51 | Sell | $273,043.26 |
Oct. 7, 2021 | Major Shareholder | 13,368 | $14.81 | Sell | $197,980.08 |
April 27, 2021 | Major Shareholder | 550,000 | $17.00 | Buy | $9,350,000.00 |
| ADMA Biologics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2021 | Major Shareholder | 82,505 | $1.16 | Sell | $95,705.80 |
Sept. 27, 2021 | Major Shareholder | 250,000 | $1.23 | Sell | $307,500.00 |
Sept. 23, 2021 | Major Shareholder | 780,000 | $1.27 | Sell | $990,600.00 |
Aug. 19, 2021 | Major Shareholder | 350,352 | $1.24 | Sell | $434,436.48 |
Aug. 17, 2021 | Major Shareholder | 879,092 | $1.35 | Sell | $1,186,774.20 |
March 19, 2020 | Major Shareholder | 500,000 | $2.10 | Buy | $1,050,000.00 |
Feb. 11, 2020 | Major Shareholder | 4,563,700 | $3.50 | Buy | $15,972,950.00 |
| Vyne Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2021 | Major Shareholder | 250,000 | $1.74 | Sell | $435,000.00 |
Aug. 12, 2021 | Major Shareholder | 338,897 | $2.23 | Sell | $755,740.31 |
May 6, 2021 | Major Shareholder | 1,000,000 | $3.67 | Sell | $3,670,000.00 |
Jan. 28, 2021 | Major Shareholder | 4,219,409 | $2.37 | Buy | $9,999,999.33 |
June 9, 2020 | Major Shareholder | 2,702,702 | $1.85 | Buy | $4,999,998.70 |
| Solid Biosciences LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 23, 2021 | Director | 2,608,695 | $5.75 | Buy | $14,999,996.25 |
| Prometheus Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 16, 2021 | Major Shareholder | 850,000 | $19.00 | Buy | $16,150,000.00 |
| Landos Biopharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 8, 2021 | Director | 1,250,000 | $16.00 | Buy | $20,000,000.00 |
| Scynexis Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 22, 2021 | Major Shareholder | 319,000 | $8.24 | Sell | $2,628,560.00 |
Jan. 20, 2021 | Major Shareholder | 185,000 | $7.43 | Sell | $1,374,550.00 |
| Motus GI Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 22, 2021 | Major Shareholder | 550,000 | $1.48 | Sell | $814,000.00 |
Jan. 20, 2021 | Major Shareholder | 325,648 | $1.80 | Sell | $586,166.40 |
| Athenex Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 14, 2020 | Major Shareholder | 1,800,000 | $11.00 | Buy | $19,800,000.00 |
Sept. 10, 2020 | Major Shareholder | 200,000 | $11.24 | Buy | $2,248,000.00 |
Oct. 16, 2019 | Major Shareholder | 67,222 | $10.29 | Buy | $691,714.38 |
Sept. 16, 2019 | Major Shareholder | 30,000 | $13.58 | Buy | $407,400.00 |
Sept. 12, 2019 | Major Shareholder | 13,584 | $14.05 | Buy | $190,855.20 |
Aug. 15, 2019 | Major Shareholder | 30,000 | $15.00 | Buy | $450,000.00 |
June 24, 2019 | Major Shareholder | 20,786 | $17.90 | Buy | $372,069.40 |
June 21, 2019 | Major Shareholder | 23,073 | $17.85 | Buy | $411,853.05 |
May 6, 2019 | Major Shareholder | 100,000 | $12.71 | Buy | $1,271,000.00 |
| Leap Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 22, 2020 | Major Shareholder | 1,750,000 | $2.00 | Buy | $3,500,000.00 |
| Amicus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 24, 2018 | Major Shareholder | 20,000 | $12.45 | Buy | $249,000.00 |
March 5, 2018 | Major Shareholder | 335,827 | $13.56 | Buy | $4,553,814.12 |
Dec. 30, 2016 | Major Shareholder | 94,750 | $4.96 | Buy | $469,960.00 |
Dec. 29, 2016 | Major Shareholder | 142,125 | $4.87 | Buy | $692,148.75 |
Dec. 23, 2016 | Major Shareholder | 85,275 | $4.81 | Buy | $410,172.75 |
Dec. 22, 2016 | Major Shareholder | 189,500 | $4.51 | Buy | $854,645.00 |
Aug. 25, 2016 | Insider | 1,100,000 | $6.81 | Sell | $7,491,000.00 |
Oct. 7, 2015 | Major Shareholder | 50,000 | $6.27 | Buy | $313,500.00 |
Oct. 6, 2015 | Major Shareholder | 750,000 | $6.71 | Buy | $5,032,500.00 |
Nov. 19, 2014 | Major Shareholder | 2,100,000 | $6.50 | Buy | $13,650,000.00 |
June 30, 2014 | Major Shareholder | 4,000,000 | $3.50 | Buy | $14,000,000.00 |
| Global Blood Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 19, 2017 | Major Shareholder | 175,000 | $38.00 | Buy | $6,650,000.00 |
| AcelRx Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2016 | Major Shareholder | 216,500 | $3.92 | Sell | $848,680.00 |
Sept. 15, 2016 | Major Shareholder | 392,850 | $3.70 | Sell | $1,453,545.00 |
Nov. 18, 2015 | Major Shareholder | 176,200 | $5.35 | Sell | $942,670.00 |
Nov. 6, 2015 | Major Shareholder | 92,100 | $4.59 | Sell | $422,739.00 |
Sept. 9, 2015 | Major Shareholder | 310,000 | $4.18 | Sell | $1,295,800.00 |
Nov. 7, 2013 | major shareholder | 200,000 | $6.51 | Buy | $1,302,000.00 |
Nov. 4, 2013 | major shareholder | 155,000 | $6.87 | Buy | $1,064,850.00 |
Nov. 1, 2013 | Major Shareholder | 360,660 | $6.91 | Buy | $2,492,160.60 |
July 23, 2013 | Major Shareholder | 850,000 | $11.65 | Buy | $9,902,500.00 |